Self Administered Drugs Market to Reflect Steady Growth Rate by 2024

Self-administered drugs are those that can be administered by the patient without the help of the medical practitioner. Self-administered drugs include over-the-counter drugs, topical prescription drugs and self-administered intravenous drugs. Intravenous self-administered drugs are administered into the body through implantable or non – implantable infusion pumps that can be regulated by the patient. Self-administered drugs are mainly consumed by patients suffering from chronic diseases like multiple sclerosis, rheumatoid arthritis, diabetes and others. With the increasing number of people suffering from chronic diseases globally the self-administered drugs are expected to witness high demand, mainly among old and working population. Moreover owing to increasing health care cost and sensitivity of drugs several drug which reduces over time medical devices manufacturers are increasing emphasis on patient self-administration of drugs.

The demand for self-administered drugs is increasing rapidly owing to the changing lifestyle of the people. Self-administration of the drugs saves time and money of the patients required for visiting the physicians or nurses. Increasing outpatient medical services is expected to boost demand for self-administered drugs over the forecast period. Government insurance organizations are providing medical coverage on some self-administered drugs which in turn is expected to increase adoption among end users. For instance, Centers for Medicare cover usually do not cover self-administered drugs however it provides medical coverage to some outpatient prescription drugs like injectable drugs, some antigens, drugs used with durable medical equipment and others. Increasing healthcare costs for patients seeking medical treatment in hospitals and increasing trend towards use of self-administered drugs among working population is expected to provide high growth opportunities among manufacturers over the forecast period.

Moreover introduction of new patient administered drugs in the disposable prefilled form aimed to address the inconvenience created through unregulated dosages and regulatory compliance is expected to increase adoption rate of self-administered drugs globally over the forecast period. However, low or no reimbursement for some self-administered drugs and increasing number of cases of side effects caused by the unregulated dose of self-administered drugs may hamper the revenue growth of the self-administered drugs market over the forecast period.

The global self-administered drugs market is segmented into following three segments: by product type, by route of administration and by geography

Segmentation by product type

Tablets
Syrups
Creams
Injectables

Segmentation by route of administration

Oral
Transdermal
Intravenous
Nasal

Segmentation by geography

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)

Geographically, North America and Europe regions are expected to contribute to the largest share of the self-administered drugs market. The shifting patient population from low to high income countries in North America and Europe is expected to propel demand for self-administered drugs over the forecast period. Asia Pacific region is expected to witness fast growth in the self-administered drugs market owing to high population in the region and growing geriatric population. Latin America and MEA regions are also expected to witness significant growth in self-administered drugs market owing to availability of the products due to increased market penetration of the market participants in these regions.

Request Sample Report @https://www.persistencemarketresearch.com/samples/12634

Some players in the self-administered drugs market are Abbott Laboratories, Bristol-Mayers Squibb, Gilead Sciences, Novartis AG, Eli Lilly & Company, Pfizer, Inc., and Antares Pharma, Inc. The market participants are focusing on competitive pricing and product innovation strategies in order to increase their market share in the global self-administered drugs market.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: himanshu.t@persistencemarketresearch.com

This release was published on openPR.